{"SPADE_N_06534": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06534", "Peptide Name": "VS-9", "Source": "garlic", "Family": "", "Gene": "Not found", "Sequence": "VKLRSLLCS", "Sequence Length": 9, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Molt-4 (IC50=0.84 mM ); K562 (IC50=1.57 mM )", "Hemolytic Activity": "Not available", "Cytotoxicity": "PBMC:IC50>2.0 mM", "Binding Target": "groove of the BH3 domain on target proteins", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C44H83N13O12S", "Mass": 1018.27, "PI": 9.51, "Net Charge": 2, "Hydrophobicity": 0.9, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Comments": "VS-9 could induce apoptosis and upregulate mRNA levels of caspase 3, caspase 8, caspase 9, and Bax while downregulating Bcl-2, Bcl-xL, and Bcl-w.", "Literature": [{"Title": "A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl-2 family proteins", "Pubmed ID": "33595876", "Reference": "Chem Biol Drug Des. 2021 May;97(5)1017-1028.", "Author": "Rasaratnam K, Nantasenamat C, Phaonakrop N, Roytrakul S, Tanyong D.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33595876"}], "Frequent Amino Acids": "LSC", "Absent Amino Acids": "ADEFGHIMNOPQTUWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06850", "Similarity": 1.0, "Sequence": "FPFFNQYVKL"}, {"SPADE_ID": "SPADE_N_06851", "Similarity": 1.0, "Sequence": "FPWFNQYVKL"}, {"SPADE_ID": "SPADE_N_06852", "Similarity": 1.0, "Sequence": "FPWWNQYVKL"}]}}}